Revolution Medicines RVMD Insider Ownership

NASDAQ RVMD

$208.80 -2.07 (-0.98%)

As of: Sep 4, 2026 · 2:23 PM EDT

Insider Holdings by Owner

11.82Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

—

share count not reported for this filer set

Shares Held by Insiders

39.74K

filed for Sep 2026

■0.00% QoQ

Shares Outstanding

189.23Mn

189,231,562 shares

Direct Holdings

39.74K

Indirect: 0

Net Shares Traded (QoQ)

no net change in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Quarter ending 30 Sep, 2026

Revolution Medicines's three largest insider shareholders as of August 29, 2026 are Rock Ventures Iii, L.P. Third (TenPercentOwner, 5.10Mn shares), Thilo Schroeder (Director, 4.74Mn shares), Thilo Schroeder (Director, 2.86Mn shares).

A detailed ownership breakdown for Revolution Medicines is not available at this time.
Per Business Quant data, insider ownership at Revolution Medicines represents 110.96% of total outstanding shares, amounting to 2.34Mn shares out of 210.89Mn outstanding.
Their holdings in Revolution Medicines increased 0.05%, from 2.34Mn shares to 2.34Mn shares over the prior quarter.
Among insider personnel at Revolution Medicines, Mark A Goldsmith (Director) bought the most shares, adding 80.00K shares in the 90-day window ending August 29, 2026.
Conversely, Mark A Goldsmith (Director) led selling activity at Revolution Medicines, with 176.02K shares sold over the same period ending August 29, 2026.

Form 4 Holdings

Insiders Holding RVMD

Insiders 19

Shares held 11.82Mn

Of outstanding 6.24%

#	Insider	Position	Direct	Indirect	Total	Share of Insiders	Last Filed
1	Rock Ventures Iii, L.P. Third	TenPercentOwner	5,104,130	0	5,104,130	43.2%	10 Jun, 2022
2	Thilo Schroeder	Director	0	2,857,481	2,857,481	24.2%	09 Dec, 2024
3	Alexis Borisy	Director	2,340,075	0	2,340,075	19.8%	23 Jun, 2026
4	Mark A Goldsmith	Director, Officer	267,330	61,424	328,754	2.8%	25 Aug, 2026
5	Stephen Michael Kelsey	Officer	291,876	0	291,876	2.5%	18 Jun, 2026
6	Margaret A Horn	Chief Operating Officer	158,222	0	158,222	1.3%	15 Jun, 2026
7	Jack Anders	Chief Financial Officer	123,269	0	123,269	1.0%	26 Jun, 2026
8	Xiaolin Wang	Officer	116,063	0	116,063	1.0%	19 Mar, 2026
9	Lin Wei	Chief Medical Officer	101,366	0	101,366	0.9%	19 Mar, 2026
10	Sandra Horning	Director	96,574	0	96,574	0.8%	30 Jun, 2025
11	Lorence H. Kim	Director	74,281	0	74,281	0.6%	23 Jun, 2026
12	Jeff Cislini	General Counsel	55,907	0	55,907	0.5%	25 Aug, 2026
13	Anthony Mancini	Officer	49,975	0	49,975	0.4%	18 Jun, 2026
14	Neil Exter	Director	28,815	0	28,815	0.2%	17 Jun, 2022
15	Flavia Borellini	Director	26,215	0	26,215	0.2%	23 Jun, 2026
16	Sushil Patel	Director	21,656	0	21,656	0.2%	01 Jul, 2026
17	Eric Thomas Schmidt	Director	21,251	0	21,251	0.2%	12 Jun, 2023
18	Frank Clyburn	Director	10,929	0	10,929	0.1%	23 Jun, 2026
19	Elizabeth M Anderson	Director	9,406	0	9,406	0.1%	23 Jun, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

1,372 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
21 Aug, 2026	Jeff Cislini	General Counsel	Acquired M	29,680	$18.56	$550.86K	86,201	Direct
21 Aug, 2026	Mark A Goldsmith	Director, Officer	Acquired M	80,000	$4.73	$378.40K	347,330	Direct
21 Aug, 2026	Jeff Cislini	General Counsel	Acquired M	26,600	$21.61	$574.83K	112,801	Direct
21 Aug, 2026	Mark A Goldsmith	Director, Officer	Disposed S	5,128	$207.23	$1.06Mn	342,202	Direct
21 Aug, 2026	Jeff Cislini	General Counsel	Disposed S	3,400	$207.24	$704.60K	109,401	Direct
21 Aug, 2026	Mark A Goldsmith	Director, Officer	Disposed S	24,917	$208.37	$5.19Mn	317,285	Direct
21 Aug, 2026	Mark A Goldsmith	Director, Officer	Disposed S	35,938	$209.26	$7.52Mn	281,347	Direct
21 Aug, 2026	Jeff Cislini	General Counsel	Disposed S	17,323	$208.37	$3.61Mn	92,078	Direct
21 Aug, 2026	Mark A Goldsmith	Director, Officer	Disposed S	3,813	$210.25	$801.67K	277,534	Direct
21 Aug, 2026	Jeff Cislini	General Counsel	Disposed S	25,817	$209.25	$5.40Mn	66,261	Direct
21 Aug, 2026	Jeff Cislini	General Counsel	Disposed S	2,540	$210.26	$534.07K	63,721	Direct
21 Aug, 2026	Mark A Goldsmith	Director, Officer	Disposed S	6,583	$211.33	$1.39Mn	270,951	Direct
21 Aug, 2026	Mark A Goldsmith	Director, Officer	Disposed S	3,621	$212.08	$767.93K	267,330	Direct
21 Aug, 2026	Jeff Cislini	General Counsel	Disposed S	4,500	$211.34	$951.04K	59,221	Direct
21 Aug, 2026	Jeff Cislini	General Counsel	Disposed S	3,314	$212.06	$702.76K	55,907	Direct
21 Aug, 2026	Mark A Goldsmith	Director, Officer	Disposed S	190	$207.25	$39.38K	64,234	Indirect
21 Aug, 2026	Mark A Goldsmith	Director, Officer	Disposed S	951	$208.36	$198.15K	63,283	Indirect
21 Aug, 2026	Jeff Cislini	General Counsel	Disposed M	29,680	$0.00	$0	0	Direct
21 Aug, 2026	Mark A Goldsmith	Director, Officer	Disposed S	1,351	$209.28	$282.74K	61,932	Indirect
21 Aug, 2026	Jeff Cislini	General Counsel	Disposed M	26,600	$0.00	$0	3,500	Direct

Showing 1 to 20 of 1,372 transactions